Legend Biotech Corp Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.00B-0.10B-0.27B-0.40B-0.45B-0.52B-0.18B
Depreciation and Depletion 0.00B0.00B0.01B0.01B0.01B0.01B0.01B
Share-based Compensation 0.00B0.02B0.03B
Gains from Sales and Divestitures 0.00B0.00B0.00B
Gains from Investment Securities -0.00B-0.00B-0.00B-0.00B-0.00B
Asset Writedowns and Impairment -0.00B
Cash from Operations 0.31B-0.08B-0.23B-0.20B-0.21B-0.44B-0.18B
Depreciation, Depletion & Amortization
Amortization of Goodwill 0.00B
Amortizatization of Intangibles 0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF) 0.00B0.00B0.01B0.01B0.01B0.02B0.02B
Change in Working Capital
Change in Receivables 0.21B0.02B-0.04B0.02B0.05B-0.10B0.09B
Change in Inventory -0.00B-0.00B-0.00B0.00B-0.01B-0.01B-0.02B
Change in Account Payables 0.00B0.00B-0.00B0.00B0.07B-0.05B0.01B
Change in Accured Expenses 0.02B0.03B0.03B0.14B0.12B-0.00B0.05B
Other Working Capital Changes -0.00B-0.00B0.00B
Investing Activities
Capital Expenditures 0.02B0.03B0.03B0.04B0.02B0.02B0.01B
Sales of Property, Plant and Equipment 0.00B0.00B0.00B0.00B
Cash from Investing Activities -0.10B-0.06B-0.02B-0.19B-0.08B0.09B-0.85B
Financing Activities
Cash from Financing Activities 0.00B0.01B0.62B0.63B0.38B0.79B0.01B
Debt Issuance and Repayment
Non-Current Debt 2000.00B2000.00B2000.00B
Current Debt -0.00B0.00B
Additional items
Exchange Rate Effect 0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B
Change in Cash 0.21B-0.13B0.37B0.23B0.10B0.49B-0.99B
Free Cash Flow 0.29B-0.11B-0.26B-0.24B-0.23B-0.46B-0.19B
Net Cash Flow 0.21B-0.13B0.36B0.23B0.09B0.44B-1.02B